NHS to fast-track access to cannabis-based medicine for children with severe epilepsy
Thousands of people, including children with severe epilepsy will have access to a potentially life changing, seizure preventing cannabis-based treatment on the NHS from the New Year.
Doctors will be able to prescribe Epidyolex with clobazam for eligible children with two types of severe epilepsy which can cause multiple seizures a day – Lennox Gastaut syndrome and Dravet syndrome.
Following an NHS England agreement with GW Pharma, NICE has been able to recommend the treatment, with access fast tracked and available from 6 January.
Clinical trials have shown the treatment could reduce the number of seizures by up to 40% in some children when used in combination with clobazam. Around 2,000 people could benefit from this new treatment every year.
Simon Stevens, NHS chief executive, said: “The NHS is committed, through the Long Term Plan, to improving the lives of all those affected by rare diseases.
“Living with or caring for someone with severe epilepsy is exceptionally challenging, especially as there are so few treatments available for the rare forms of the condition.
“Thousands of people including children will now have access to this treatment, which has the potential to make a real difference.”
NHS England published earlier this year a review aimed at assessing the barriers to prescribing cannabis-based medicinal products where it is safe and clinically appropriate. Work has started with the Department of Health and Social Care and other partners to implement the recommendations – and a letter to the NHS to clarify the procedure for prescribing unlicensed cannabis-based products where there is an unmet need and it is clinically appropriate will be issued shortly.
Latest News from
NHS tells gambling giants to improve the odds for mental health17/01/2020 09:15:00
The head of mental health care in England has written to the heads of top gambling firms, demanding urgent action to tackle betting-related ill health.
Primary Care Network service specifications and the Network DES: close of engagement16/01/2020 14:15:00
In December 2019, we published five draft service specifications for engagement; these followed agreement with the British Medical Association General Practitioners Committee (BMA GPC) in January 2019 that the five specifications would form part of the Network DES for 2020/21.
UK Government tackles heart disease with new partnership15/01/2020 13:14:00
The UK Government has announced its intent to pursue an innovative new collaboration to tackle heart disease with pharmaceutical company Novartis.
New heart disease drug to be made available for NHS patients14/01/2020 14:19:00
The government is collaborating with pharmaceutical company Novartis to launch a clinical trial for new cholesterol treatment.
Older people encouraged to ditch “stiff upper lip” approach to mental ill health13/01/2020 16:10:00
NHS England and Age UK have joined forces in a campaign to encourage older people to access treatment for mental health conditions, as new analysis shows a majority of older people do not seek help.
DNA Testing On The NHS To Fast Track Diagnosis For Critically Ill Babies And Children03/01/2020 15:15:15
The NHS in England is providing a new form of DNA test capable of rapidly diagnosing rare diseases for critically ill babies and children, as part of its Long Term Plan to use world leading technologies to improve care for the sickest infants.
England’s top doctor slams ‘exploitative’ party drips02/01/2020 15:15:15
So-called ‘party drips’ are ineffective and potentially harmful, said England’s top doctor recently, as he criticised companies for peddling fake health remedies to the public.
NHS Support Sees People Lose The Weight Of 43 Ambulances02/01/2020 11:05:00
People finishing the world leading NHS Diabetes Prevention Programme have lost the equivalent weight of 43 ambulances